Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle FunctionalizationDiana Dehaini, Liangfang Zhang, Xiaoli Wei et al.|Advanced Materials|2017Cited by 756
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432F. Wang, Rui‐Hua Xu, Xiaoli Wei et al.|Annals of Oncology|2019Cited by 475
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)Feng‐Hua Wang, Rui‐Hua Xu, Yunpeng Liu et al.|Journal of Clinical Oncology|2021Cited by 350
Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophagesQingshan Wang, Yue Wang, Ní Hóng et al.|Cell Research|2010Cited by 216
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratioXiaoli Wei, Rui‐Hua Xu, Feng‐Hua Wang et al.|BMC Cancer|2015Cited by 160